📢 Cipla Limited share price surged 2.21% 📈following Q3 FY25 results🚀 🔹Revenue from Operations: ₹7,072.97 Cr ( ↑ 7.1 % YoY from ₹6,603.81 Cr )🔥 🔹Net Profit: ₹1,574.59 Cr (↑ 47% YoY from ₹1,068.41 Cr)🔥 🔹Pharmaceutical Revenue: ₹6,777.84 Cr (↑ 6.5% YoY from ₹6,365.06 Cr)🔥 🔹New ventures Revenue: ₹341.30 Cr (↑ 22% YoY from ₹280.51 Cr)🔥 🔹EPS: ₹19.45 (↑ 49% YoY from ₹13.08)📈 Solid profitability growth and stable revenue 💰📊